Precision medicine in B-cell lymphoid malignancies: is it possible?

On demand Janssen satellite symposium from the virtual ESH CLL congress 2021

Introduction - What do we mean by precision medicine in B-cell lymphoid malignancies?
Kostas Stamatopoulos

Structured roundtable panel discussion: Is biology-driven clinical management possible…
• in chronic lymphocytic leukemia?
• in Waldenström’s macroglobulinemia?
• in diffuse large B-cell lymphoma?
All faculty, moderated by Kostas Stamatopoulos

Questions and answers
• Questions submitted by the audience
All faculty, moderated by Kostas Stamatopoulos

Closing remarks
Kostas Stamatopoulos


Learning objective:

After participating in this symposium, delegates should be able to:

  • Discuss the role of precision medicine in the management of patients with B-cell lymphoid malignancies 



  • Kostas Stamatopoulos (Greece)
  • Gianluca Gaidano (Italy)
  • Steve Treon (USA)
  • Catherine Thieblemont (France)


More Info
61 Minutes
EM-71288 - Date of preparation: August 2021